POY_1170x120_8-12-19

migraine medication

Mayne Pharma releases Bupap generic

Mayne Pharma releases Bupap generic

GREENVILLE, N.C. — Mayne Pharma Inc. has launched butalbital acetaminophen tablets 50 mg/300 mg, a migraine medication, in the United States. Mayne said Thursday that it will distribute the product, a generic version of Bupap tablets (butalbital acetaminophen 50 mg/300 mg) from Valeant Pharmaceuticals International, on behalf of its partner Mikart Inc., the developer and

Eli Lilly to acquire CoLucid for $960 million

Eli Lilly to acquire CoLucid for $960 million

INDIANAPOLIS — Eli Lilly and Co. plans to buy CoLucid Pharmaceuticals Inc., maker of a promising migraine medication, for about $960 million in cash. Cambridge, Mass.-based CoLucid is currently in development with lasmiditan tablets, indicated for acute treatment of migraine, and has completed the first of two Phase 3 trials. A data read-out for the